Kristen E Stevenson
Overview
Explore the profile of Kristen E Stevenson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
3452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wu W, Nelson G, Koch R, Donovan K, Nowak R, Heavican-Foral T, et al.
Blood
. 2021 Dec;
139(13):2024-2037.
PMID: 34936696
Immunomodulatory (IMiD) agents like lenalidomide and pomalidomide induce the recruitment of IKZF1 and other targets to the CRL4CRBN E3 ubiquitin ligase, resulting in their ubiquitination and degradation. These agents are...
12.
Tran T, Langlois S, Meloche C, Caron M, Saint-Onge P, Rouette A, et al.
Blood Adv
. 2021 Dec;
6(4):1329-1341.
PMID: 34933343
The molecular hallmark of childhood acute lymphoblastic leukemia (ALL) is characterized by recurrent, prognostic genetic alterations, many of which are cryptic by conventional cytogenetics. RNA sequencing (RNA-seq) is a powerful...
13.
Valtis Y, Stevenson K, Place A, Silverman L, Vrooman L, Gotti G, et al.
Blood Adv
. 2021 Oct;
6(1):72-81.
PMID: 34610104
Adolescent and young adult patients with acute lymphoblastic leukemia (ALL) have superior outcomes when treated on pediatric regimens. Pediatric ALL regimens rely heavily on corticosteroids and asparaginase and are known...
14.
Vrooman L, Blonquist T, Stevenson K, Supko J, Hunt S, Cronholm S, et al.
J Clin Oncol
. 2021 Jul;
39(31):3496-3505.
PMID: 34228505
Purpose: Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia (ALL) Consortium Protocol 11-001 assessed efficacy and toxicity of calaspargase pegol (calaspargase), a novel pegylated asparaginase formulation with longer half-life, compared with the...
15.
Valvert F, Silva O, Solorzano-Ortiz E, Puligandla M, Siliezar Tala M, Guyon T, et al.
Blood Adv
. 2021 May;
5(10):2447-2455.
PMID: 33988700
Inadequate diagnostics compromise cancer care across lower- and middle-income countries (LMICs). We hypothesized that an inexpensive gene expression assay using paraffin-embedded biopsy specimens from LMICs could distinguish lymphoma subtypes without...
16.
Bernard E, Nannya Y, Hasserjian R, Devlin S, Tuechler H, Medina-Martinez J, et al.
Nat Med
. 2021 May;
27(5):927.
PMID: 33948021
No abstract available.
17.
Bernard E, Nannya Y, Hasserjian R, Devlin S, Tuechler H, Medina-Martinez J, et al.
Nat Med
. 2021 Feb;
27(3):562.
PMID: 33564192
No abstract available.
18.
Zhou X, Yang J, Ringbloom K, Martinez-Escala M, Stevenson K, Wenzel A, et al.
Blood Adv
. 2021 Feb;
5(3):649-661.
PMID: 33560380
Primary cutaneous follicle center lymphomas (PCFCLs) are indolent B-cell lymphomas that predominantly remain skin restricted and manageable with skin-directed therapy. Conversely, secondary cutaneous involvement by usual systemic follicular lymphoma (secondary...
19.
Burns M, Place A, Stevenson K, Gutierrez A, Forrest S, Pikman Y, et al.
Pediatr Blood Cancer
. 2021 Jan;
68(3):e28885.
PMID: 33506554
No abstract available.
20.
Layer J, Debaize L, Van Scoyk A, House N, Brown A, Liu Y, et al.
Proc Natl Acad Sci U S A
. 2020 Oct;
117(44):27566-27577.
PMID: 33077594
Recent studies have implicated DNA polymerases θ (Pol θ) and β (Pol β) as mediators of alternative nonhomologous end-joining (Alt-NHEJ) events, including chromosomal translocations. Here we identify subunits of the...